American Regent clears one contamination recall, starts another

American Regent in Shirley, NY, is again hearing the hum of production and shipping activities in its injectables business, resuming shipments last week of such multisource products as Venofer (iron sucrose injection). The company is working with the FDA drug shortage staff to prioritize critical medications. Twenty products have been released and shipped so far, according to an announcement.

The shipping follows an investigation into glass delamination prompted by several product recalls. The company suspended production at the plant, reports in-Pharma Technologist.

The company says it can confirm the products now being shipped were manufactured in accordance with cGMP requirements. "American Regent is confident in the integrity and quality of these injectable products," according to the announcement.

Separately, the company initiated a recall of one lot of caffeine & sodium benzoate injection. Some vials may contain visible particles.

- here's the American Regent announcement
- get the article from in-Pharma Technologist
- see the recall story


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.